• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) TRIFECTA STENTED TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) TRIFECTA STENTED TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Device Problems Leak/Splash (1354); Perivalvular Leak (1457); Patient-Device Incompatibility (2682)
Patient Problems Low Cardiac Output (2501); Pericardial Effusion (3271)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, after the valve implantation further surgical intervention was needed in some patients.This was intervention was either implanting an intra-aortic balloon pump, re-exploration for bleeding, pericardial effusion, and paravalular leakage.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
Reference manufacturing number: 3007113487-2019-00042, 3007113487-2019-00044, 3007113487-2019-00045, 3007113487-2019-00046, 3007113487-2019-00047.It was reported through a research article identifying trifects that may be related to surgical intervention.The patient demographics are 73.5 +/-6.4 years old, with 54.1% male and 45.9% female.Details are listed in the article, titled [durability and clinical experience using a bovine pericardial prosthetic aortic valve].It was reported in the article that 1,241 patients were implanted with a trifecta bioprosthetic aortic valve.The patients had a history of aortic valve stenosis, aortic valve insufficiency, peripheral vascular disease, coronary artery disease, pulmonary disease, stroke, hypertension, diabetes, hyperlipidemia and kidney disease.Surgical intervention was performed for the following: 40 patients had a surgical intervention of intra-aortic balloon pump due to low co syndrome, 92 patients had re-exploration for bleeding, two patient had pericardial effusion, and one patient had paravalvular leakage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA STENTED TISSUE VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer (Section G)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9527323
MDR Text Key174411765
Report Number3007113487-2019-00043
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 12/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/03/2019
Initial Date FDA Received12/27/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-